Condition: Generalized Anxiety Disorder · Sponsor: Beijing Union Pharmaceutical Factory Ltd
A placebo-controlled superiority design was used to evaluate the efficacy of 60 mg/ day or 120 mg/ day of Buagafuran capsules in the treatment of GAD
This description comes directly from the study's public registry record.
Tao Sun · 13621169498 · sunny.suntao@aliyun.com
Always discuss trial participation with your own doctor first.
| Beijing Union Pharmaceutical Factory Ltd | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06243640